Back to Search
MORTON COLEMAN, MD
MD
Hematology & Oncology Physician
NPI: 1851460406Individual
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
101065(NY)
Research & Publications (20)
Low-dose metronomic, multidrug therapy with the PEP-C oral combination chemotherapy regimen for mantle cell lymphoma.
PMID 18297520·Leuk Lymphoma·2008
8-other
Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.
PMID 18338745·Cancer·2008
3-trial
Inhalation anthrax: dose response and risk analysis.
PMID 18582166·Biosecur Bioterror·2008
7-preclinical
Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies.
PMID 18349031·Ann Oncol·2008
8-other
Early 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography scanning in the lymphomas: changing the paradigms of treatments?
PMID 16933331·Cancer·2006
8-other
Primate auditory diversity and its influence on hearing performance.
PMID 15470672·Anat Rec A Discov Mol Cell Evol Biol·2004
4-observational
Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone.
PMID 12720151·Semin Oncol·2003
3-trial
BLT-D (clarithromycin [Biaxin], low-dose thalidomide, and dexamethasone) for the treatment of myeloma and Waldenström's macroglobulinemia.
PMID 12685831·Leuk Lymphoma·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 407 E 70TH ST, 3RD FLOOR
NEW YORK, NY 10021 - Phone
- (212) 517-5900
Quick Facts
- NPI
- 1851460406
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile